28 July 2003
Blood serum and neutrophil L-arginine concentrations and nitric oxide release by neutrophils in chronic uremic patients and healthy persons
Jacek Rysz, Piotr Guga, Tomasz Grycewicz, Janusz Mudyna, Marek LuciakMed Sci Monit 2003; 9(7): CR311-315 :: ID: 12957
Abstract
Background:Plasma levels of L-arginine have previously been evaluated in several studies to reveal either down- or up-regulation of the L-arginine/NO pathway in chronic uremia.Material/Methods:We studied L-arginine plasma levels along with intracellular neutrophil concentration and NO release by peripheral blood neutrophils in patients with chronic uremia.Results:The L-arginine plasma concentration was found to be significantly higher (64.4I12.0 Kmol/L) in chronic uremic patients (n=25) than in healthy controls (33.0?I10.0 Kmol/L; n=25). Neutrophil homogenate L-arginine levels were substantially increased in uremic patients (7.95?I1.10 nmol/108 cells) as compared with controls (5.22I0.46 nmol/108 cells). The in vitro release of NO by unstimulated neutrophils was lower in uremic patients (0.14?I0.05? Kmol•s–1) than in healthy persons (0.48I0.20 Kmol•s–1). The NO release after uremic neutrophil stimulation with 10–6 M fMLP was 21.42I2.13 Kmol•s–1, while after PMA it was 31.01I1.99 Kmol•s–1. NO release after normal neutrophil stimulation with 10–7 M fMLP was 19.52I2.32 Kmol•s–1, and after PMA was 28.63I3.06 Kmol•s–1.Conclusions:In chronic uremic patients plasma and neutrophil concentrations of L-arginine were significantly higher. However, there were no significant differences in NO release between normal and uremic neutrophils after stimulation. Our findings may have implications for the impact of the L-arginine-nitric oxide signaling pathway on the pathophysiological changes in the L-arginine: NO pathway seen in chronic uremia.
Keywords: Arginine - blood, Neutrophils - metabolism, Nitric Oxide - metabolism, Signal Transduction - physiology, Uremia - blood
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952